Repeated introductions and intensive community transmission fueled a mumps virus outbreak in Washington State

  1. Louise Hillier Moncla  Is a corresponding author
  2. Allison Black
  3. Chase DeBolt
  4. Misty Lang
  5. Nicholas R Graff
  6. Ailyn C Pérez-Osorio
  7. Nicola F Müller
  8. Dirk Haselow
  9. Scott Lindquist
  10. Trevor Bedford  Is a corresponding author
  1. Fred Hutchinson Cancer Research Center, United States
  2. University of Washington, United States
  3. Washington State Department of Health, United States
  4. Arkansas Department of Health, United States

Abstract

In 2016/2017, Washington State experienced a mumps outbreak despite high childhood vaccination rates, with cases more frequently detected among school-aged children and members of the Marshallese community. We sequenced 166 mumps virus genomes collected in Washington and other US states, and traced mumps introductions and transmission within Washington. We uncover that mumps was introduced into Washington approximately 13 times, primarily from Arkansas, sparking multiple co-circulating transmission chains. Although age and vaccination status may have impacted transmission, our dataset could not quantify their precise effects. Instead, the outbreak in Washington was overwhelmingly sustained by transmission within the Marshallese community. Our findings underscore the utility of genomic data to clarify epidemiologic factors driving transmission, and pinpoint contact networks as critical for mumps transmission. These results imply that contact structures and historic disparities may leave populations at increased risk for respiratory virus disease even when a vaccine is effective and widely used.

Data availability

All code used to analyze data, input files for BEAST, and all code used to generate figures for this manuscript are publicly available at https://github.com/blab/mumps-wa-phylodynamics. Raw FASTQ files with human reads removed are available under SRA project number PRJNA641715. All protocols for generating sequence data as well as the consensus genomes are available at https://github.com/blab/mumps-seq. Consensus genomes have also been deposited to Genbank under accessions MT859507-MT859672.

The following data sets were generated

Article and author information

Author details

  1. Louise Hillier Moncla

    Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, SEATTLE, United States
    For correspondence
    lhmoncla@gmail.com
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0001-5722-1988
  2. Allison Black

    University of Washington, Seattle, United States
    Competing interests
    The authors declare that no competing interests exist.
  3. Chase DeBolt

    Office of Communicable Disease Epidemiology, Washington State Department of Health, Shoreline, United States
    Competing interests
    The authors declare that no competing interests exist.
  4. Misty Lang

    Office of Communicable Disease Epidemiology, Washington State Department of Health, Shorelinee, United States
    Competing interests
    The authors declare that no competing interests exist.
  5. Nicholas R Graff

    Office of Communicable Disease Epidemiology, Washington State Department of Health, Shoreline, United States
    Competing interests
    The authors declare that no competing interests exist.
  6. Ailyn C Pérez-Osorio

    Office of Communicable Disease Epidemiology, Washington State Department of Health, Shoreline, United States
    Competing interests
    The authors declare that no competing interests exist.
  7. Nicola F Müller

    Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, SEATTLE, United States
    Competing interests
    The authors declare that no competing interests exist.
  8. Dirk Haselow

    Epidemiology, Arkansas Department of Health, Little Rock, United States
    Competing interests
    The authors declare that no competing interests exist.
  9. Scott Lindquist

    Office of Communicable Disease Epidemiology, Washington State Department of Health, Shoreline, United States
    Competing interests
    The authors declare that no competing interests exist.
  10. Trevor Bedford

    Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, United States
    For correspondence
    tbedford@fredhutch.org
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-4039-5794

Funding

National Science Foundation (DGE-1256082)

  • Allison Black

Life Sciences Research Foundation

  • Louise Hillier Moncla

National Institutes of Health (R35 GM119774-01)

  • Trevor Bedford

The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.

Copyright

This is an open-access article, free of all copyright, and may be freely reproduced, distributed, transmitted, modified, built upon, or otherwise used by anyone for any lawful purpose. The work is made available under the Creative Commons CC0 public domain dedication.

Metrics

  • 1,306
    views
  • 155
    downloads
  • 15
    citations

Views, downloads and citations are aggregated across all versions of this paper published by eLife.

Download links

A two-part list of links to download the article, or parts of the article, in various formats.

Downloads (link to download the article as PDF)

Open citations (links to open the citations from this article in various online reference manager services)

Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)

  1. Louise Hillier Moncla
  2. Allison Black
  3. Chase DeBolt
  4. Misty Lang
  5. Nicholas R Graff
  6. Ailyn C Pérez-Osorio
  7. Nicola F Müller
  8. Dirk Haselow
  9. Scott Lindquist
  10. Trevor Bedford
(2021)
Repeated introductions and intensive community transmission fueled a mumps virus outbreak in Washington State
eLife 10:e66448.
https://doi.org/10.7554/eLife.66448

Share this article

https://doi.org/10.7554/eLife.66448

Further reading

    1. Immunology and Inflammation
    2. Microbiology and Infectious Disease
    Daniel Spari, Annina Schmid ... Guido Beldi
    Research Article

    Sepsis causes millions of deaths per year worldwide and is a current global health priority declared by the WHO. Sepsis-related deaths are a result of dysregulated inflammatory immune responses indicating the need to develop strategies to target inflammation. An important mediator of inflammation is extracellular adenosine triphosphate (ATP) that is released by inflamed host cells and tissues, and also by bacteria in a strain-specific and growth-dependent manner. Here, we investigated the mechanisms by which bacteria release ATP. Using genetic mutant strains of Escherichia coli (E. coli), we demonstrate that ATP release is dependent on ATP synthase within the inner bacterial membrane. In addition, impaired integrity of the outer bacterial membrane notably contributes to ATP release and is associated with bacterial death. In a mouse model of abdominal sepsis, local effects of bacterial ATP were analyzed using a transformed E. coli bearing an arabinose-inducible periplasmic apyrase hydrolyzing ATP to be released. Abrogating bacterial ATP release shows that bacterial ATP suppresses local immune responses, resulting in reduced neutrophil counts and impaired survival. In addition, bacterial ATP has systemic effects via its transport in outer membrane vesicles (OMV). ATP-loaded OMV are quickly distributed throughout the body and upregulated expression of genes activating degranulation in neutrophils, potentially contributing to the exacerbation of sepsis severity. This study reveals mechanisms of bacterial ATP release and its local and systemic roles in sepsis pathogenesis.

    1. Biochemistry and Chemical Biology
    2. Microbiology and Infectious Disease
    Qiong He, Miao-Miao Zhao ... Jin-Kui Yang
    Research Article

    Diabetes, a prevalent chronic condition, significantly increases the risk of mortality from COVID-19, yet the underlying mechanisms remain elusive. Emerging evidence implicates Cathepsin L (CTSL) in diabetic complications, including nephropathy and retinopathy. Our previous research identified CTSL as a pivotal protease promoting SARS-CoV-2 infection. Here, we demonstrate elevated blood CTSL levels in individuals with diabetes, facilitating SARS-CoV-2 infection. Chronic hyperglycemia correlates positively with CTSL concentration and activity in diabetic patients, while acute hyperglycemia augments CTSL activity in healthy individuals. In vitro studies reveal high glucose, but not insulin, promotes SARS-CoV-2 infection in wild-type cells, with CTSL knockout cells displaying reduced susceptibility. Utilizing lung tissue samples from diabetic and non-diabetic patients, alongside Leprdb/dbmice and Leprdb/+mice, we illustrate increased CTSL activity in both humans and mice under diabetic conditions. Mechanistically, high glucose levels promote CTSL maturation and translocation from the endoplasmic reticulum (ER) to the lysosome via the ER-Golgi-lysosome axis. Our findings underscore the pivotal role of hyperglycemia-induced CTSL maturation in diabetic comorbidities and complications.